Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,162 | 32,912 | 88,952 | 43,231 | 31,063 |
| Marketable Securities | 41,857 | 55,722 | 11,997 | 25,983 | 39,950 |
| Receivables | N/A | 500 | N/A | N/A | N/A |
| TOTAL | $80,034 | $90,625 | $102,596 | $70,039 | $71,861 |
| Non-Current Assets | |||||
| PPE Net | 2,894 | 2,649 | 2,550 | 2,490 | 1,945 |
| Other Non-Current Assets | 227 | 146 | 146 | 146 | 146 |
| TOTAL | $3,121 | $2,795 | $2,696 | $2,636 | $2,091 |
| Total Assets | $83,155 | $93,420 | $105,292 | $72,675 | $73,952 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,011 | 758 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,510 | 2,160 | 1,678 | 2,198 | 1,177 |
| Accrued Expenses | 8,376 | 7,440 | 7,254 | 5,413 | 4,769 |
| Other current liabilities | 600 | 125 | 12 | N/A | 1 |
| TOTAL | $16,273 | $12,588 | $11,049 | $9,716 | $8,052 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,835 | 14,069 | 14,808 | 14,789 | 6,676 |
| Deferred Revenues | 1,776 | 2,105 | 2,105 | 2,105 | 2,105 |
| Other Non-Current Liabilities | 2,222 | 1,570 | 1,522 | 1,171 | 2,235 |
| TOTAL | $15,057 | $15,837 | $17,054 | $17,210 | $10,687 |
| Total Liabilities | $31,330 | $28,425 | $28,103 | $26,926 | $18,739 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,419 | 52,858 | 52,769 | 41,686 | 41,416 |
| Common Shares | 53 | 53 | 53 | 41 | 41 |
| Retained earnings | -252,587 | -232,933 | -218,798 | -206,301 | -195,617 |
| Other shareholders' equity | -12 | -10 | 0 | -10 | -36 |
| TOTAL | $51,825 | $64,995 | $77,189 | $45,749 | $55,213 |
| Total Liabilities And Equity | $83,155 | $93,420 | $105,292 | $72,675 | $73,952 |